AMED Research Program on Emerging and Re-emerging Infectious Disesses.
Study of antitoxins/antivenoms and their replacement by humanized monoclonal antibodies.[Ato Group]

Blog Blog

2021.01.31

Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU First Update

Serum therapy for COVID-19 is described below.

For adults with severe or critical COVID-19, we suggest against the use convalescent plasma outside clinical trials (weak recommendation).